Drug Type Small molecule drug |
Synonyms GCPII 抑制剂 - IN-1, 前列腺特异性膜抗原(PSMA)抑制剂 - IN-1 |
Target |
Action inhibitors |
Mechanism PSMA inhibitors(Prostate-specific membrane antigen inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Nervous System Diseases | Preclinical | China | 25 Oct 2025 | |
| Prostatic Cancer | Preclinical | China | 25 Oct 2025 |





